Trainings By Informa Markets in India
Informa


India IP Conclave

18 Nov - 19 Nov 2020   |   Virtual Course


Course Overview

With an overarching theme in the Indian Pharmaceutical industry of “Ideate and Innovate”, CPhI Conferences concluded the, ‘9th Annual Pharma IPR India Conference’ on 6th March 2020 at Taj Santacruz, Mumbai. With 230 attendees & 37 unique pharma companies, 52 distinguished speakers and 27 event partners from 5 countries, this forum experienced the congregation of the pharma intellectual property fraternity under one roof.

Innovation is a key consideration in day-to-day business decisions. Protection of these innovations is the key to business success. With the ever-increasing technological developments; new products, brands and creative designs are launched daily in the market and reflects continuous human creativity. In today’s intellectual era, Indian companies have adapted research and development (R&D) for describing its growth momentum. The Indian government has supported the R&D culture by creating a conducive environment by upgrading infrastructure and bringing in policy level initiatives in the country which has resulted in sweeping changes in IP culture and administration in the country.

For the Indian companies to maximize its true potential, ideate, innovate and integrate are pre-requisites to reaching the stupendous growth. With recent chant of ‘Atmanirbhar Bharat’ along with ‘Make in India’, ‘Start-up India’ and ‘Digital India’ initiatives; the government of India envisages, “An India where creativity and innovation are stimulated by Intellectual Property for the benefit of all”. It aims to defining knowledge as the main driver of development. Intellectual Property promotes advancement in science and technology, arts and culture, traditional knowledge and biodiversity resources.

After 9 successful edition of Pharma IPR Conference, CPhI Conferences is pleased to introduce its premier edition of IP Conclave webinar series scheduled on 18th-19th November 2020.

Benefits of Attending


Understand the recent developments on Hatch-Waxman and BPCIA

Get updates on the guidelines amended by US FDA on ANDA filing for US region

Gain insights of Unitary Patent Law

Understand how Brexit has impacted the Indian pharma companies which want to enter European regions

Acquire in-depth knowledge of key IP issues in European and UK market

Understand how Indian Pharma and Biopharma industry is planning to enter new regions like South Africa / Middle East

Cater to rising opportunities due to increasing number of patent expiration globally

Understand the updated guidelines globally

Gain insights on 2019 Biosimilars Guideline


Associate Partner

Strategic Partner

Who Should Attend?


Industries / Categories

  • Pharmaceuticals & Biotech
  • FMCG
  • Media and Entertainment
  • Online Platforms & E-commerce
  • Automotive
  • Food & Beverages
  • Information Technology

Designation

  • VP
  • Head
  • Senior Managers
  • Managers
  • General Manager
  • Executives
  • In- house Counsels

Departments

  • IPR
  • IP Cell
  • Patents
  • Legal department




Similar Courses


Basel III LCR & NSFR Ratios

View Details

09 Nov - 11 Nov 2020

Virtual Course

Download Brochure  

Register  

Interest Rate Risk in the Banking Book

View Details

17 Nov - 18 Nov 2020

Virtual Course

Download Brochure  

Register  

cGMP Workshop

View Details

18 Nov - 19 Nov 2020

Virtual Course

Download Brochure  

Register  

MASTERING PAT & QbD THROUGH LIFECYCLE PROCESS VALIDATION

View Details

18 Nov - 19 Nov 2020

Virtual Course

Download Brochure  

Register